Ferric Ammonium Citrate Effervescent Granules

• 

Founded in 1992, BeijingBeiluPharmaceuticalsCompanyLimitedis mainly engaged in the research & development, production and sales of pharmaceutical products. It is high-tech innovation company with core competence in the Contrast Mediumdomestic. It has around 650 employees with 0.82 Bn/￥ revenue in 2019. Beilu provides complete Contrast Media products suitable for X-Ray and Magnetic Resonance Imaging (MRI), and it is the leading manufacturer in the Contrast Media field in China. It is one of the 1st batches of listed enterprises in GEM of SZSE (Ticker: 300016.SZ) in China.

Mist Ferric Ammonium Citrate Effervescent Granules was launched in 2004. It is an oral contrast agent / oral contrast media approved by NMPA in the market, which is a safe and effective double contrast agent with the advantages of convenient use of ferric ammonium citrate / ammonium citrate uses and good safety. This ammonium iron citrate can significantly improve the images quality of MRCP and MRU, and can also be used as a positive contrast agent for the digestive tract. We provide ferric ammonium nitrate, ferric ammonium citrate and potassium ferricyanide,etc.

Product name: Ferric Ammonium Citrate Effervescent Granules

Type: Oral MRI Contrast Media

Ingredients: Ferric ammonium citrate

Specification: 3g: 0.6g（Fe 129mg), 6g: 1.2g（Fe 258mg）

Posology and method of administration: Oral

Adverse reactions: Foreign clinical data reported that after using this MRI contrast medium, 0.1-0.5% of patients has diarrhea, 0.1% had nausea, vomiting, and decreased appetite, and a very small number of patients has stomach discomfort and bloating. All the above symptoms can be eliminated by themselves.
Shelf life: 24 months

Indications of Ferric Ammonium Citrate Effervescent Granules
Used for magnetic resonance abdominal imaging, angiography of the digestive tract (stomach duodenum and jejunum).

Precautions of Ferric Ammonium Citrate Effervescent Granules
Use with caution in the following patients: patients with the gastrointestinal tract such as peptic ulcer, ulcerative colitis, local enteritis, etc.

The stool appearing black after administration is a normal phenomenon.

During the ammonium citrate uses, false-positive for occult blood may occur.

Другие товары поставщика

	Diethylenetriaminepentaacetic acid (DTPA)	Diethylenetriaminepentaaceticacid (DTPA) CAS No.: 67-43-6 Molecular formula: C₁₄H₂₃N₃O₁₀ Molecular weight: 393.35 Quality standard: CP ...
	Contrast Media Manufacturing Company	For the purpose of medical imaging, a certain substance is introduced into the human body to change the image contrast of local tissues of the body...
	Repaglinide Tablets	Repaglinide tablets are non-sulfonylurea insulin secretion agents and are used to treat patients with type 2 diabetes. Repaglinide tablets were lis...
	Anti-Diabetic Drugs	The number of people with diabetes rose from 151 million in 2000 to 463 million in 2019; by 2045 this number will rise to 700 million. 1 in 5 of th...
	Gadobutrol Injection/API	In 2020, Beilu launched its macrocyclic Contrast Media- Gadobutrol Injection, it is gadolinium-based non-ionic Contrast Media, a paramagnetic Contr...

Похожие товары

	Chlortetracycline Premix	Продавец: Hebei Shengxue Dacheng Pharmaceutical Co., Ltd.	Precautions for the use of Chlortetracycline Premix in livestock feed 1. Strict compliance: &midd...
	Chlortetracycline Premix	Продавец: Hebei Shengxue Dacheng Pharmaceutical Co., Ltd.	Chlortetracycline Premix in livestock and poultry feed: 1. Purpose: · Promote the growth o...
	Chlortetracycline Premix	Продавец: Hebei Shengxue Dacheng Pharmaceutical Co., Ltd.	Uses of Chlortetracycline Premix ·Livestock and poultry health: Chlortetracycline Premix i...
	Chlortetracycline Premix	Продавец: Hebei Shengxue Dacheng Pharmaceutical Co., Ltd.	Characteristics of Chlortetracycline Premix ·Natural fermentation products: Chlortetracycl...
	Chlortetracycline Premix	Продавец: Hebei Shengxue Dacheng Pharmaceutical Co., Ltd.	Chlortetracycline Premix is a feed additive that combines chlortetracycline with premix technolog...